Ars Pharmaceuticals Inc (SPRY)

Ars Pharmaceuticals Inc (SPRY) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	-	-	-	0.01	0.02
Operating Expenses	29.00% 13.19	10.23	17.98	20.61	18.73
Operating Income/Loss	29.00% -13.19	-10.23	-17.98	-20.60	-18.71
Income/Loss From Continuing Operations Before Tax	-10.29	-	-14.87	0.01	0.02
Income/Loss From Continuing Operations After Tax	43.58% -10.29	-7.168	-14.87	-17.37	-14.96
Net Income/Loss	43.58% -10.29	-7.168	-14.87	-17.37	-14.96
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	31,503% 96.49	0.3053	95.58	94.91	94.23
Diluted Average Shares	31,503% 96.49	0.3053	95.58	94.91	94.23
Basic Earnings Per Share	57.14% -0.11	-0.07	-0.16	-0.18	-0.16
Diluted Earnings Per Share	57.14% -0.11	-0.07	-0.16	-0.18	-0.16
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-